Shareholders approve 2019 EIP amendment, increase share pool by 4M; directors elected

Milestone Pharmaceuticals Inc.

Proposal to amend 2019 EIP to remove evergreen provision and add 4,000,000 shares approved (8.04M for, 4.74M against, 14.9M broker non-votes).
All eight director nominees elected: Joseph Oliveto, Stuart Duty, Seth Fischer, Lisa Giles, Joseph Papa, Andrew Saik, Michael Tomsicek, Robert Wills.
Ratification of PwC as auditor passed with 28.1M for, 284k against, 159k abstentions.
Non-binding advisory vote on executive compensation (9.2M for, 3.6M against) and triennial frequency (12.3M for 1-year) passed.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.